TGF-beta RII Binding Proteins for Therapeutic Use

The European Patent Office published patent application EP4081306A1 by Merus B.V. for TGF-beta-RII binding proteins for therapeutic use. The application covers cancer treatment applications (A61P 35/00) and is classified under C07K 16/28 and C07K 16/10. The patent designates all EPC contracting states and was published March 25, 2026.

Methods of Administering Voxelotor for Sickle Cell Disease Treatment

The European Patent Office published patent application EP4061368A1 for methods of administering voxelotor, a sickle cell disease treatment developed by Global Blood Therapeutics, Inc. The application was published on March 25, 2026 with IPC classifications covering A61K 31/4439 (pyridine derivatives) and A61P 7/00 (blood disorders). The patent is designated across 34 European member states.

Vidal v. Venettozzi - Prison Disciplinary Due Process

The Second Circuit vacated the SDNY's grant of summary judgment to New York DOCCS officials in Vidal v. Venettozzi, holding that 180-270 days of disciplinary segregation in the Special Housing Unit constitutes an atypical and significant hardship under Sandin v. Conner, thereby implicating a protected liberty interest under the Fourteenth Amendment. The court remanded for further proceedings on whether Vidal received constitutionally adequate due process protections at his disciplinary hearing.

Waldman v. Palestine Liberation Org. - Terrorism Litigation

The Second Circuit decided a motion in Waldman v. Palestine Liberation Org., a consolidated terrorism litigation case involving multiple plaintiffs who are victims of terrorist attacks. The court addressed appeals in Docket Nos. 15-3135-cv, 15-3151-cv, and 22-1060-cv. The motion decision affects the procedural posture of claims against the Palestine Liberation Organization and Palestinian Authority.

Ramsay v. Bondi - Immigration Motion to Reopen

The Second Circuit granted John Marcus Ramsay's petition challenging the BIA's denial of his motion to reopen removal proceedings, finding the BIA misread his arguments regarding equitable tolling and due diligence. The court reversed and remanded for reconsideration consistent with United States v. Minter, which held the statute of conviction (NYPL § 220.39(1)) categorically overbroad as compared to the federal CSA. Ramsay, a 70-year-old Jamaican lawful permanent resident and Navy veteran deported in 2007, was paroled back to the US pending this litigation.

Petersen Energía v. Argentine Republic - Shareholder Expropriation

The Second Circuit partially reversed a $16.1 billion damages award in favor of minority shareholders Petersen Energía and Eton Park against Argentina and YPF S.A., finding breach of contract damages claims are not cognizable under Argentine law. The court affirmed the district court's finding that Argentina violated Argentine law through expropriation but reversed on damages theories and remanded for further proceedings.

Rivera-Perez wins habeas appeal, Second Circuit, March 26

Rivera-Perez wins habeas appeal, Second Circuit, March 26

Georgia Local Democracy Jeopardized - Congress Report

The Congress of Local and Regional Authorities of the Council of Europe issued a report finding local democracy in Georgia to be in jeopardy, citing rapid democratic backsliding, high polarisation, one-party rule over local authorities, and lack of follow-up on past recommendations. The Congress debated findings from a fact-finding visit conducted September 24-25, 2025, and deplored irregularities in the October 4, 2025 local elections including widespread boycotts, electoral law changes, and intimidation of opposition voices.

Ukrainian local and national authorities unite for reconstruction

Ukrainian local and national authorities unite for reconstruction

Crystalline Nitrogen-Containing Heterocyclic Compound Patent Application

The European Patent Office published patent application EP4480952A1 filed by Shanghai Pharmaceuticals Holding Co., Ltd. for a crystalline form of a nitrogen-containing heterocyclic compound with anti-cancer applications. The application covers the compound's chemical structure, preparation methods, and therapeutic uses under IPC classification C07D471/04.